File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A cost-analysis of risperidone in the treatment of chronic schizophrenia with predominating negative symptoms in Hong Kong

TitleA cost-analysis of risperidone in the treatment of chronic schizophrenia with predominating negative symptoms in Hong Kong
Authors
KeywordsChronic Disorder
Cost-analysis
Negative Symptoms
Risperidone
Schizophrenia
Issue Date2000
PublisherHong Kong College of Psychiatrists. The Journal's web site is located at http://www.hkjpsych.com/search.jsp
Citation
Hong Kong Journal Of Psychiatry, 2000, v. 10 n. 3, p. 14-20+43-44 How to Cite?
AbstractA comparative study of risperidone and conventional anti-psychotic therapy was performed for out-patients with schizophrenia with predominantly negative symptoms. After 3 months, there was a significant change in the Brief Psychiatric Rating Scale, Scale for Assessment of Negative Symptoms and Clinical Global Impression scores in the patients receiving risperidone, together with a better employment status. Both treatments appeared to be cost-beneficial, but risperidone was more cost-effective compared with conventional anti-psychotic therapy for this group of patients. Various limitations of the study are discussed and some clinical implications that warrant further studies to confirm the present findings have been suggested.
Persistent Identifierhttp://hdl.handle.net/10722/154123
ISSN
2012 SCImago Journal Rankings: 0.158
References

 

DC FieldValueLanguage
dc.contributor.authorMak, KYen_HK
dc.contributor.authorNg, Sen_HK
dc.contributor.authorWong, MCen_HK
dc.contributor.authorFung, SCen_HK
dc.date.accessioned2012-08-08T08:23:22Z-
dc.date.available2012-08-08T08:23:22Z-
dc.date.issued2000en_HK
dc.identifier.citationHong Kong Journal Of Psychiatry, 2000, v. 10 n. 3, p. 14-20+43-44en_HK
dc.identifier.issn1026-2121en_HK
dc.identifier.urihttp://hdl.handle.net/10722/154123-
dc.description.abstractA comparative study of risperidone and conventional anti-psychotic therapy was performed for out-patients with schizophrenia with predominantly negative symptoms. After 3 months, there was a significant change in the Brief Psychiatric Rating Scale, Scale for Assessment of Negative Symptoms and Clinical Global Impression scores in the patients receiving risperidone, together with a better employment status. Both treatments appeared to be cost-beneficial, but risperidone was more cost-effective compared with conventional anti-psychotic therapy for this group of patients. Various limitations of the study are discussed and some clinical implications that warrant further studies to confirm the present findings have been suggested.en_HK
dc.languageengen_US
dc.publisherHong Kong College of Psychiatrists. The Journal's web site is located at http://www.hkjpsych.com/search.jspen_HK
dc.relation.ispartofHong Kong Journal of Psychiatryen_HK
dc.subjectChronic Disorderen_HK
dc.subjectCost-analysisen_HK
dc.subjectNegative Symptomsen_HK
dc.subjectRisperidoneen_HK
dc.subjectSchizophreniaen_HK
dc.titleA cost-analysis of risperidone in the treatment of chronic schizophrenia with predominating negative symptoms in Hong Kongen_HK
dc.typeArticleen_HK
dc.identifier.emailNg, S: ngsiuman@hku.hken_HK
dc.identifier.emailWong, MC: mcmwong@hkucc.hku.hken_HK
dc.identifier.emailFung, SC: sfung@hku.hken_HK
dc.identifier.authorityNg, S=rp00611en_HK
dc.identifier.authorityWong, MC=rp00024en_HK
dc.identifier.authorityFung, SC=rp00695en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.scopuseid_2-s2.0-0034466981en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0034466981&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume10en_HK
dc.identifier.issue3en_HK
dc.identifier.spage14en_HK
dc.identifier.epage20+43en_HK
dc.publisher.placeHong Kongen_HK
dc.identifier.scopusauthoridMak, KY=7102680251en_HK
dc.identifier.scopusauthoridNg, S=7403358478en_HK
dc.identifier.scopusauthoridWong, MC=26029250900en_HK
dc.identifier.scopusauthoridFung, SC=7201970040en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats